课题基金 / 基金详情

项目摘要

项目成果

Carlos L Arteaga的其他基金

相似基金

相关文献

中文摘要
翻译
西蒙斯综合癌症中心(SCCC)的愿景是成为翻译领域的卓越领导者。 癌症预防和世界级护理的科学发现,重点是社区参与 努力消除德克萨斯州及其他地区的癌症差异。SCCC的使命是: 通过突破性发现、跨学科研究和有影响力的社区, 参与、教育和卓越的患者护理。它是通过多方面的、动态的规划来实现的 在全面战略计划以及内部和外部投入的指导下, 外部咨询机构。著名的翻译研究员和中心主任卡洛斯L。Arteaga,MD,谁 2017年从范德比尔特-英格拉姆癌症中心抵达,在领导重塑一个 为SCCC注入新的使命、愿景和路线图。Arteaga经验丰富、敬业的八人团队 副董事组成执行委员会(EC),负责就 制定SCCC管理的政策和实践,并优先考虑新的机会, 投资.更重要的是,欧盟委员会负责
英文摘要
Simmons Comprehensive Cancer Center’s (SCCC) vision is to become a preeminent leader in translating scientific discovery into cancer prevention and world-class care with an emphasis on community engagement efforts to eradicate cancer disparities in Texas and beyond. This vision is realized though SCCC’s mission to ease the burden of cancer through ground-breaking discovery, transdisciplinary research, impactful community engagement, education, and exceptional patient care. It is pursued through a multi-faceted, dynamic planning and evaluation process that is guided by a comprehensive strategic plan as well as input from both internal and external advisory entities. Renowned translational researcher and Center Director Carlos L. Arteaga, MD, who arrived from the Vanderbilt-Ingram Cancer Center in 2017, has been instrumental in leading efforts to recast a reinvigorated mission, vision, and road map for SCCC. Arteaga’s highly experienced and engaged team of eight Associate Directors form an Executive Committee (EC), which is responsible for advising him on the establishment of policies and practices for the management of SCCC and prioritizing new opportunities and investments. More importantly, the EC is responsible for the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    9759820
  • 项目类别:
  • 资助金额:
    $35.74万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10214565
  • 项目类别:
  • 资助金额:
    $36.83万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10458531
  • 项目类别:
  • 资助金额:
    $36.09万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: